Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Lung (Non-Small Cell)
Study Phase
Phase 3
Study Completion Date
June 2013
NCT00981058Uploaded 10-16-2018
Available for Download
PDS UID: LungNo_EliLill_2010_272
A Randomized, Multicenter, Open-Label Phase 3 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Gemcitabine-Cisplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
Files:
PROTOCOLV6-0 Protocol CP11-0806-redact_v3.pdf
CRFjfcc_acrf_redacted.pdf
DATA DICTIONARYjfcc_adam_define_redacted.pdf
DATA (COMPARATOR ARM)jfcc_deid_ctrl_trt.zip